Analystreport

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its price target raised by analysts at SVB Leerink LLC from $40.00 to $46.00. They now have an "outperform" rating on the stock.

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com